Evidence map›Paper›PMID 35983281›Full record

ArticleACS pharmacology & translational science2022

Luminogenic HiBiT Peptide-Based NanoBRET Ligand Binding Assays for Melatonin Receptors.

Florence Gbahou, Sergiy Levin, Irina G Tikhonova, Gloria Somalo Barranco, Charlotte Izabelle, Rachel Friedman Ohana, Ralf Jockers

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS pharmacology & translational science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Target Engagement Assays in Early Drug Discovery.Journal of medicinal chemistry · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Florence GbahouUniversité Paris Cité, Institut Cochin, INSERM, CNRS, 75014 Paris, France.ORCID https://orcid.org/0000-0002-2795-378X
Sergiy LevinPromega Corporation, Fitchburg, Wisconsin 53711, United States.
Irina G TikhonovaSchool of Pharmacy, Medical Biology Centre, Queen's University Belfast, Belfast BT9 7BL, United Kingdom.ORCID https://orcid.org/0000-0002-6228-9431
Gloria Somalo BarrancoUniversité Paris Cité, Institut Cochin, INSERM, CNRS, 75014 Paris, France.
Charlotte IzabelleUniversité Paris Cité, Institut Cochin, INSERM, CNRS, 75014 Paris, France.
Rachel Friedman OhanaPromega Corporation, Fitchburg, Wisconsin 53711, United States.
Ralf JockersUniversité Paris Cité, Institut Cochin, INSERM, CNRS, 75014 Paris, France.ORCID https://orcid.org/0000-0002-4354-1750
Centre National de la Recherche Scientifique · FRPromega (United States) · USQueen's University Belfast · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The two human melatonin receptors MT

Identifiers

PMID35983281
PMCPMC9380205
OpenAlexW4285727679

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.